Drug intelligence / Profile preview

clotrimazole

Development stage
Approved
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral, Topical, Vaginal
01

Overview

Clotrimazole is a broad-spectrum antifungal medication in the imidazole class, primarily used to treat various fungal infections such as tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete's foot), cutaneous candidiasis, oral thrush, vaginal yeast infections, diaper rash, and tinea versicolor. Its mechanism of action involves inhibiting the enzyme lanosterol 14-alpha demethylase in fungi, which impairs ergosterol synthesis—a critical component of the fungal cell membrane—leading to increased membrane permeability and inhibition of fungal growth. At higher concentrations, it may be fungicidal. Clotrimazole also exhibits additional pharmacological effects by inhibiting sarcoplasmic reticulum Ca2+-ATPase and blocking certain calcium-dependent channels[1][2][3][5].

Brand names
LotriminLotrimin AFMycelexClotrim AntifungalCruex Prescription StrengthCanestenClotrimadermDesenexMyclo-DermNeo-Zol
Other names
clotrimazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)ATP2A (Sarcoplasmic reticulum Ca2+-ATPase)KCNN4 (Intermediate conductance calcium-activated potassium channel protein 4)

Beyond the preview

Go deeper on clotrimazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotrimazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call